Patents Represented by Attorney Beth E. Foley, Hoag & Eliot LLP Arnold, Esq.

Find this attorney in the Justia Lawyer Directory

  • Assays for diagnosing type II diabetes in a subject
    Patent number: 5800998
    Abstract: Assays for determining whether a subject has or is at risk for developing type II diabetes, which are based on detecting the presence or absence of alterations in the hepatic nuclear factor 1 (HNF-1) gene or protein of the subject are disclosed.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: September 1, 1998
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventor: M. Alexandra Glucksmann
  • Methods for identifying compounds useful in treating type II diabetes
    Patent number: 5795726
    Abstract: Methods for identifying compounds, which modulate the bioactivity of human hepatic nuclear factor-1 (HNF-1), and which are therefore useful in treating type II diabetes are disclosed.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: August 18, 1998
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventor: M. Alexandra Glucksmann
  • Ubiquitin conjugating enzymes
    Patent number: 5744343
    Abstract: The present invention concerns three ubiquitin-conjugating enzymes.
    Type: Grant
    Filed: September 13, 1994
    Date of Patent: April 28, 1998
    Assignee: Mitotix, Inc.
    Inventors: Giulio Draetta, Mark Rolfe, Jens W. Eckstein, Guillaume Cottarel